PepTalk 2022 | San Diego, CA & Virtual
Jan 17, 2022
Absci CTO Matthew Weinstock will be presenting, “Enabling the Discovery and Production of Next-Generation Biologics via Synthetic Biology and Artificial Intelligence” on Wednesday, January 19th at 10:05 AM PST as part of the Recombinant Protein Expression and Production track. For more information please visit the conference home page or find the full agenda here.
Enabling the Discovery and Production of Next-Generation Biologics via Synthetic Biology and Artificial Intelligence
Recent advances in synthetic biology and artificial intelligence promise to dramatically impact the way that pharmaceuticals are developed. In this presentation I will discuss how Absci is leveraging the power of these technologies to address key pain points in both how protein-based biologics are discovered as well as how cell lines for manufacturing are designed.
Presenter: Matthew Weinstock, CTO, Absci